Literature DB >> 12715123

[Selected dermatological diseases of the genital region].

B Schütte1.   

Abstract

Physicians who are not trained in dermatology often experience difficulty interpreting skin lesions. There seem to be a number of similar lesions, which are difficult to categorize. Thus, in this presentation the various dermatological diagnoses of cutaneous genital diseases are not listed systematically, e.g., cutaneous infections, cutaneous tumors. This presentation is based on the so-called "Effloreszenzen". They are lesions such as macules, papules, and ulcers, which are typical for various skin diseases. Knowledge of these skin lesions is helpful in categorizing skin diseases, not only those of the genital region.

Entities:  

Mesh:

Year:  2003        PMID: 12715123     DOI: 10.1007/s00120-003-0323-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  4 in total

1.  European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts.

Authors:  G von Krogh; C J Lacey; G Gross; R Barrasso; A Schneider
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

2.  [Imiquimod: a new treatment possibility in bowenoid papulosis?].

Authors:  B Wigbels; T Luger; D Metze
Journal:  Hautarzt       Date:  2001-02       Impact factor: 0.751

3.  [Treatment of endemic scabies with allethrin, permethrin and ivermectin. Evaluation of a treatment strategy].

Authors:  U Paasch; U F Haustein
Journal:  Hautarzt       Date:  2001-01       Impact factor: 0.751

4.  Successful treatment of anogenital lichen sclerosus with topical tacrolimus.

Authors:  Markus Böhm; Uta Frieling; Thomas A Luger; Gisela Bonsmann
Journal:  Arch Dermatol       Date:  2003-07
  4 in total
  1 in total

1.  [Tyson's glands. On eponymic and discussion in urology and dermatology].

Authors:  F H Moll; T Halling; J Leissner; H Fangerau
Journal:  Urologe A       Date:  2015-06       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.